Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 22, 2010
SLCO1B1 polymorphism and oral antidiabetic drugsAnnikka Kalliokoski, Pertti J Neuvonen, Mikko Niemi
European Journal of Clinical Pharmacology|May 25, 2010
Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
British Journal of Clinical Pharmacology|June 23, 2004
Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinJari J Lilja, Mikko Neuvonen, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|September 17, 2004
Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazoneMikko Niemi, Janne T Backman, Pertti J Neuvonen
British Journal of Clinical Pharmacology|August 27, 2005
Effects of grapefruit juice on the absorption of levothyroxineJari J Lilja, Kalevi Laitinen, Pertti J Neuvonen
European Journal of Clinical Pharmacology|October 9, 2010
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
British Journal of Clinical Pharmacology|November 25, 2005
Effects of grapefruit juice on the pharmacokinetics of acebutololJari J Lilja, Kari Raaska, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|December 21, 2006
Drug interactions with lipid-lowering drugs: mechanisms and clinical relevancePertti J Neuvonen, Mikko Niemi, Janne T Backman
British Journal of Clinical Pharmacology|August 16, 2011
CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
Pharmacogenomics|December 25, 2007
Global analysis of genetic variation in SLCO1B1Marja K Pasanen, Pertti J Neuvonen, Mikko Niemi
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Basic & Clinical Pharmacology & Toxicology|April 22, 2010
SLCO1B1 polymorphism and oral antidiabetic drugsAnnikka Kalliokoski, Pertti J Neuvonen, Mikko Niemi
European Journal of Clinical Pharmacology|May 25, 2010
Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskirenTuija Tapaninen, Pertti J Neuvonen, Mikko Niemi
British Journal of Clinical Pharmacology|June 23, 2004
Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinJari J Lilja, Mikko Neuvonen, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|September 17, 2004
Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazoneMikko Niemi, Janne T Backman, Pertti J Neuvonen
British Journal of Clinical Pharmacology|August 27, 2005
Effects of grapefruit juice on the absorption of levothyroxineJari J Lilja, Kalevi Laitinen, Pertti J Neuvonen
European Journal of Clinical Pharmacology|October 9, 2010
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
British Journal of Clinical Pharmacology|November 25, 2005
Effects of grapefruit juice on the pharmacokinetics of acebutololJari J Lilja, Kari Raaska, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|December 21, 2006
Drug interactions with lipid-lowering drugs: mechanisms and clinical relevancePertti J Neuvonen, Mikko Niemi, Janne T Backman
British Journal of Clinical Pharmacology|August 16, 2011
CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
Pharmacogenomics|December 25, 2007
Global analysis of genetic variation in SLCO1B1Marja K Pasanen, Pertti J Neuvonen, Mikko Niemi
Pageof 20